3-TRIFLUOROACETYLAMINO LINAGLIPTIN
UNII ZAG57DVY7E

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-trifluoroacetylamino Linagliptin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZAG57DVY7E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1673546-62-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ZAG57DVY7E
CAS Registry Number
1673546-62-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
3-TRIFLUOROACETYLAMINO LINAGLIPTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C27H27F3N8O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
IQUUOPZPFJAZJX-QGZVFWFLSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
91810720
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(C#CC)n1c2c(nc1N3C[C@H](NC(C(F)(F)F)=O)CCC3)n(C)c(=O)n(Cc4nc5c(c(C)n4)cccc5)c2=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-trifluoroacetylamino Linagliptin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LINAGLIPTIN IMPURITY F

Systematic Nomenclature

(R)-N-(1-(7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)PIPERIDIN-3-YL)-2,2,2-TRIFLUOROACETAMIDE
3-TRIFLUOROACETYLAMINO LINAGLIPTIN
ACETAMIDE, N-((3R)-1-(7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)-3-PIPERIDINYL)-2,2,2-TRIFLUORO-
N-((3R)-1-(7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)-3-PIPERIDINYL)-2,2,2-TRIFLUOROACETAMIDE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound